Yehuda Kamari

Dr. Yehuda Kamari


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Journal of Hepatology
Verified
Journal Article
Closed access
YKYehuda Kamari
Yehuda Kamari
ASAviv Shaish
Aviv Shaish
EVEinav Vax
Einav Vax
SSShay Shemesh
Shay Shemesh
MKMichal Kandel-Kfir
Michal Kandel-Kfir
DHDror Harats
Dror Harats

11 August 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SUShiri Uri-Belapolsky
Shiri Uri-Belapolsky
ASAviv Shaish
Aviv Shaish
EEEfrat Eliyahu
Efrat Eliyahu
HGHadas Grossman
Hadas Grossman
MLMattan Levi
Mattan Levi
YKYehuda Kamari
Yehuda Kamari
Significance: Females are subjected to a biological clock that dictates the end of the reproductive lifespan, on average, at 50 y of age, whereas fecundity sharply decreases after 30 y of age. Over the past decade, a current trend of postponing childbearing into advanced age has led to a corresponding upward trend in the number of in vitro fertilization (IVF) treatments. Inflammation was reported to affect both IVF outcomes and the ovarian reserve adversely. Identifying a possible culprit, such as IL-1, may offer new insight into the mechanisms responsible for oocyte loss as well as practical interventions, such as IL-1 blockade, which aims to slow down the rate at which oocytes are eliminated and improve IVF outcomes.

1 February 2011 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YKYehuda Kamari
Yehuda Kamari
ASAviv Shaish
Aviv Shaish
SSShay Shemesh
Shay Shemesh
EVEinav Vax
Einav Vax
IGItamar Grosskopf
Itamar Grosskopf
DHDror Harats
Dror Harats

1 May 2014 in Digestive and Liver Disease
Verified
Journal Article
Closed access
SOSarita Olteanu
Sarita Olteanu
MKMichal Kandel-Kfir
Michal Kandel-Kfir
ASAviv Shaish
Aviv Shaish
TATal Almog
Tal Almog
SSShay Shemesh
Shay Shemesh
YKYehuda Kamari
Yehuda Kamari

19 July 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
SBSapir Bechor
Sapir Bechor
NRNoa Zolberg Relevy
Noa Zolberg Relevy
AHAyelet Harari
Ayelet Harari
TATal Almog
Tal Almog
YKYehuda Kamari
Yehuda Kamari
ASAviv Shaish
Aviv Shaish
Cholesterol efflux from macrophages is a key process in reverse cholesterol transport and, therefore, might inhibit atherogenesis. 9-cis-β-carotene (9-cis-βc) is a precursor for 9-cis-retinoic-acid (9-cis-RA), which regulates macrophage cholesterol efflux. Our objective was to assess whether 9-cis-βc increases macrophage cholesterol efflux and induces the expression of cholesterol transporters. Enrichment of a mouse diet with βc from the alga Dunaliella led to βc accumulation in peritoneal macrophages. 9-cis-βc increased the mRNA levels of CYP26B1, an enzyme that regulates RA cellular levels, indicating the formation of RA from βc in RAW264.7 macrophages. Furthermore, 9-cis-βc, as well as all-trans-βc, significantly increased cholesterol efflux to high-density lipoprotein (HDL) by 50% in RAW264.7 macrophages. Likewise, food fortification with 9-cis-βc augmented cholesterol efflux from macrophages ex vivo. 9-cis-βc increased both the mRNA and protein levels of ABCA1 and apolipoprotein E (APOE) and the mRNA level of ABCG1. Our study shows, for the first time, that 9-cis-βc from the diet accumulates in peritoneal macrophages and increases cholesterol efflux to HDL. These effects might be ascribed to transcriptional induction of ABCA1, ABCG1, and APOE. These results highlight the beneficial effect of βc in inhibition of atherosclerosis by improving cholesterol efflux from macrophages.

1 October 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
MKMichal Kandel-Kfir
Michal Kandel-Kfir
TATal Almog
Tal Almog
ASAviv Shaish
Aviv Shaish
GSGadi Shlomai
Gadi Shlomai
LALiat Anafi
Liat Anafi
YKYehuda Kamari
Yehuda Kamari